FolC2‐mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri

Bacterial‐derived compounds from the intestinal microbiome modulate host mucosal immunity. Identification and mechanistic studies of these compounds provide insights into host–microbial mutualism. Specific Lactobacillus reuteri strains suppress production of the proinflammatory cytokine, tumor necrosis factor (TNF), and are protective in a mouse model of colitis. Human‐derived L. reuteri strain ATCC PTA 6475 suppresses intestinal inflammation and produces 5,10‐methenyltetrahydrofolic acid polyglutamates. Insertional mutagenesis identified the bifunctional dihydrofolate synthase/folylpolyglutamate synthase type 2 (folC2) gene as essential for 5,10‐methenyltetrahydrofolic acid polyglutamate biosynthesis, as well as for suppression of TNF production by activated human monocytes, and for the anti‐inflammatory effect of L. reuteri 6475 in a trinitrobenzene sulfonic acid‐induced mouse model of acute colitis. In contrast, folC encodes the enzyme responsible for folate polyglutamylation but does not impact TNF suppression by L. reuteri. Comparative transcriptomics between wild‐type and mutant L. reuteri strains revealed additional genes involved in immunomodulation, including previously identified hdc genes involved in histidine to histamine conversion. The folC2 mutant yielded diminished hdc gene cluster expression and diminished histamine production, suggesting a link between folate and histadine/histamine metabolism. The identification of genes and gene networks regulating production of bacterial‐derived immunoregulatory molecules may lead to improved anti‐inflammatory strategies for digestive diseases.

[1]  M. Brosnan,et al.  Division of labour: how does folate metabolism partition between one-carbon metabolism and amino acid oxidation? , 2015, The Biochemical journal.

[2]  V. de Crécy-Lagard,et al.  Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes , 2015, Front. Genet..

[3]  C. S. Satish Kumar,et al.  Protective effect of Lactobacillus plantarum 21, a probiotic on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. , 2015, International immunopharmacology.

[4]  Emily B. Hollister,et al.  From Prediction to Function Using Evolutionary Genomics: Human-Specific Ecotypes of Lactobacillus reuteri Have Diverse Probiotic Functions , 2014, Genome biology and evolution.

[5]  V. de Crécy-Lagard.  Variations in metabolic pathways create challenges for automated metabolic reconstructions: Examples from the tetrahydrofolate synthesis pathway , 2014, Computational and structural biotechnology journal.

[6]  M. Miranda-Carús,et al.  Macrophage uptake and accumulation of folates are polarization‐dependent in vitro and in vivo and are regulated by activin A , 2014, Journal of leukocyte biology.

[7]  P. Gaburri,et al.  A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[8]  P. Hemarajata,et al.  Lactobacillus reuteri-Specific Immunoregulatory Gene rsiR Modulates Histamine Production and Immunomodulation by Lactobacillus reuteri , 2013, Journal of bacteriology.

[9]  U. Kopylov,et al.  The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab , 2013, Gut.

[10]  I. Ordás,et al.  Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. , 2013, Journal of Crohn's & colitis.

[11]  Haimei Zhao,et al.  Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice. , 2013, World journal of gastroenterology.

[12]  Ronan M. T. Fleming,et al.  Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut , 2013, Gut microbes.

[13]  G. Salvador,et al.  Lactobacillus reuteri CRL1098 soluble factors modulate tumor necrosis factor alpha production in peripheral blood mononuclear cells: involvement of lipid rafts. , 2012, International immunopharmacology.

[14]  T. Hansen,et al.  Immunology: Vitamins prime immunity , 2012, Nature.

[15]  Malcolm J. McConville,et al.  MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.

[16]  H. Kiyono,et al.  Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon , 2012, The Journal of Immunology.

[17]  T. R. Licht,et al.  Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. , 2012, Beneficial microbes.

[18]  Y. Belkaid,et al.  Dietary and commensal derived nutrients: shaping mucosal and systemic immunity. , 2012, Current opinion in immunology.

[19]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[20]  P. Hemarajata,et al.  Histamine Derived from Probiotic Lactobacillus reuteri Suppresses TNF via Modulation of PKA and ERK Signaling , 2012, PloS one.

[21]  Tzu-Hao Cheng,et al.  Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. , 2011, International immunopharmacology.

[22]  D. Gevers,et al.  Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis , 2011, Inflammatory bowel diseases.

[23]  Bas Teusink,et al.  Exploring Metabolic Pathway Reconstruction and Genome-Wide Expression Profiling in Lactobacillus reuteri to Define Functional Probiotic Features , 2011, PloS one.

[24]  S. Raimondi,et al.  Folate Production by Probiotic Bacteria , 2011, Nutrients.

[25]  J. Walter,et al.  Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm , 2010, Proceedings of the National Academy of Sciences.

[26]  L. Peyrin-Biroulet,et al.  Anti-TNF therapy in inflammatory bowel diseases: a huge review. , 2010, Minerva gastroenterologica e dietologica.

[27]  J. Versalovic,et al.  Probiotics-host communication , 2010, Gut microbes.

[28]  S. Haddadin,et al.  Intraperitoneal drug therapy: an advantage. , 2010, Current clinical pharmacology.

[29]  R. Savard,et al.  Intermediate chains of exopolysaccharides from Lactobacillus rhamnosus RW‐9595M increase IL‐10 production by macrophages , 2010, Journal of applied microbiology.

[30]  M. Livingston,et al.  Gut commensal Lactobacillus reuteri 100‐23 stimulates an immunoregulatory response , 2010, Immunology and cell biology.

[31]  A. V. van Bodegraven,et al.  Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. , 2009, World journal of gastroenterology.

[32]  S. Roos,et al.  Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[33]  James Versalovic,et al.  Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors , 2009, BMC Microbiology.

[34]  James Versalovic,et al.  Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c‐Jun , 2008, Inflammatory bowel diseases.

[35]  T. Sako,et al.  Suppressive Effect on Activation of Macrophages by Lactobacillus casei Strain Shirota Genes Determining the Synthesis of Cell Wall-Associated Polysaccharides , 2008, Applied and Environmental Microbiology.

[36]  W. D. de Vos,et al.  High-Level Folate Production in Fermented Foods by the B12 Producer Lactobacillus reuteri JCM1112 , 2008, Applied and Environmental Microbiology.

[37]  D. Chung,et al.  Lipoteichoic Acid Isolated from Lactobacillus plantarum Inhibits Lipopolysaccharide-Induced TNF-α Production in THP-1 Cells and Endotoxin Shock in Mice1 , 2008, The Journal of Immunology.

[38]  S. Sakaguchi,et al.  Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. , 2007, Immunity.

[39]  J. Versalovic,et al.  The Early Response to Acid Shock in Lactobacillus reuteri Involves the ClpL Chaperone and a Putative Cell Wall-Altering Esterase , 2007, Applied and Environmental Microbiology.

[40]  M. Comalada,et al.  A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis , 2007, British Journal of Nutrition.

[41]  B. Foligné,et al.  Recommendations for Improved Use of the Murine TNBS-Induced Colitis Model in Evaluating Anti-inflammatory Properties of Lactic Acid Bacteria: Technical and Microbiological Aspects , 2006, Digestive Diseases and Sciences.

[42]  M. Karagianni,et al.  Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. , 2005, World journal of gastroenterology.

[43]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Claesson,et al.  Colitic Scid Mice Fed Lactobacillus spp. Show an Ameliorated Gut Histopathology and an Altered Cytokine Profile by Local T Cells , 2005, Inflammatory bowel diseases.

[45]  T. Hartung,et al.  Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Bibiloni,et al.  VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis , 2005, The American Journal of Gastroenterology.

[47]  M. Yazdanbakhsh,et al.  Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. , 2005, The Journal of allergy and clinical immunology.

[48]  J. Versalovic,et al.  Probiotic Lactobacillus spp. Diminish Helicobacter hepaticus-Induced Inflammatory Bowel Disease in Interleukin-10-Deficient Mice , 2005, Infection and Immunity.

[49]  J. Walter,et al.  A High-Molecular-Mass Surface Protein (Lsp) and Methionine Sulfoxide Reductase B (MsrB) Contribute to the Ecological Performance of Lactobacillus reuteri in the Murine Gut , 2005, Applied and Environmental Microbiology.

[50]  J. Versalovic,et al.  Genotypic and Phenotypic Studies of Murine Intestinal Lactobacilli: Species Differences in Mice with and without Colitis , 2004, Applied and Environmental Microbiology.

[51]  J. Hugenholtz,et al.  Effects of Cultivation Conditions on Folate Production by Lactic Acid Bacteria , 2003, Applied and Environmental Microbiology.

[52]  D. Downs,et al.  Metabolic Flux in Both the Purine Mononucleotide and Histidine Biosynthetic Pathways Can Influence Synthesis of the Hydroxymethyl Pyrimidine Moiety of Thiamine in Salmonella enterica , 2002, Journal of bacteriology.

[53]  J. Pestka,et al.  Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells1 , 2002, The Journal of Immunology.

[54]  B. Chait,et al.  Automatic identification of proteins with a MALDI-quadrupole ion trap mass spectrometer. , 2001, Analytical chemistry.

[55]  G. Reuter.  The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. , 2001, Current issues in intestinal microbiology.

[56]  B. Fowler.  The folate cycle and disease in humans. , 2001, Kidney international. Supplement.

[57]  R. Korpela,et al.  Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on Acetic Acid-Induced Colitis in Rats , 2001, Scandinavian journal of gastroenterology.

[58]  Tetsuya Hayashi,et al.  Molecular Analysis of the folC Gene of Pseudomonas aeruginosa , 2000, Microbiology and immunology.

[59]  B. Kirschner,et al.  Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study , 2000, Journal of pediatric gastroenterology and nutrition.

[60]  M. Kindy,et al.  Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. , 2000, Cytokine.

[61]  J. Reilly,et al.  Observation of tetrahydrofolylpolyglutamic acid in bacteria cells by matrix-assisted laser desorption/ionization mass spectrometry. , 2000, Analytical biochemistry.

[62]  A. Whitehead,et al.  Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.

[63]  E. Maguin,et al.  New thermosensitive plasmid for gram-positive bacteria , 1992, Journal of bacteriology.

[64]  C. Holdsworth,et al.  The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. , 1991, Journal of medical microbiology.

[65]  A. Bognar,et al.  Cloning and expression of the gene encoding Lactobacillus casei folylpoly-gamma-glutamate synthetase in Escherichia coli and determination of its primary structure. , 1990, The Journal of biological chemistry.

[66]  J. Wallace,et al.  Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.

[67]  I. Eto,et al.  Determination of three different pools of reduced one-carbon-substituted folates. III. Reversed-phase high-performance liquid chromatography of the azo dye derivatives of p-aminobenzoylpoly-gamma-glutamates and its application to the study of unlabeled endogenous pteroylpolyglutamates of rat liver. , 1982, Analytical biochemistry.

[68]  I. Eto,et al.  Determination of three different pools of reduced one-carbon-substituted folates. 1. A study of the fundamental chemical reactions. , 1980, Analytical biochemistry.

[69]  H. P. Broquist.  Evidence for the involvement of folic acid in histidine synthesis in microorganisms. , 1957, Archives of biochemistry and biophysics.

[70]  Lukasz Krzysztof.  Lactobacillus reuteri , 2016, Reactions Weekly.

[71]  S. Ragsdale.  Catalysis of methyl group transfers involving tetrahydrofolate and B(12). , 2008, Vitamins and hormones.

[72]  Jean Yee Hwa Yang,et al.  Gene expression Identifying differentially expressed genes from microarray experiments via statistic synthesis , 2005 .

[73]  A. Bognar,et al.  Mutagenesis of the folC gene encoding folylpolyglutamate synthetase-dihydrofolate synthetase in Escherichia coli. , 1991, Archives of biochemistry and biophysics.

[74]  A. Bognar,et al.  Bacterial folylpoly(gamma-glutamate) synthase-dihydrofolate synthase. , 1986, Methods in enzymology.